Hedge Funds Aren't Crazy About Meridian Bioscience, Inc. (VIVO) Anymore
Is Meridian Bioscience, Inc.
Meridian Bioscience Inc (VIVO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Springbok Capital Gavin Saitowitz And Cisco J. Del Valle | 0 | $0 | 0% | |
| 3. | Pentwater Capital Management Matthew Halbower | 0 | $0 | 0% | |
| 4. | Sand Grove Capital Partners Simon Davies | 0 | $0 | 0% | |
| 5. | Gotham Asset Management Joel Greenblatt | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.87 | 4,028 | Officer | 11,528 | 2022-02-25 | Filing | |
| $17.65 | 5,000 | Director | 10,851 | 2020-11-25 | Filing | |
| $17.99 | 5,000 | Director | 5,851 | 2020-08-11 | Filing | |
| $6.02 | 1,550 | Director | 5,717 | 2020-03-16 | Filing | |
| $5.78 | 30,000 | Officer, Director | 238,324 | 2020-03-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.39 | 61,437 | Officer, Director | 265,131 | 2022-06-27 | Filing | |
| $30.00 | 13,559 | Officer, Director | 265,131 | 2022-06-24 | Filing | |
| $29.98 | 19,956 | Officer, Director | 265,131 | 2022-06-23 | Filing | |
| $29.72 | 44,651 | Officer, Director | 265,131 | 2022-06-22 | Filing | |
| $25.60 | 20,000 | Officer | 83,048 | 2022-02-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1 | $34 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
Hedge Fund and Insider Trading News: Crispin Odey, Stanley Druckenmiller, Bill Miller, Renaissance Technologies, Elliott Management, ApaH Capital, Harley-Davidson Inc (HOG), Meridian Bioscience Inc (VIVO), and More
For years, Renaissance Technologies was among the most exalted names in high finance, as close to a sure-thing as Wall Street had.
Is VIVO A Good Stock To Buy Now?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Hedge Funds Are Crazy About Meridian Bioscience, Inc. (VIVO)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Did Hedge Funds Make The Right Call On Meridian Bioscience, Inc. (VIVO) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Have Never Been This Bullish On Meridian Bioscience, Inc. (VIVO)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Meridian Bioscience, Inc. (VIVO): Are Hedge Funds Right About This Stock?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Is Meridian Bioscience, Inc. (VIVO) Going to Burn These Hedge Funds?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Here's What Hedge Funds Think About Meridian Bioscience, Inc. (VIVO)
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first quarter...
Here's What Hedge Funds Think About Meridian Bioscience, Inc. (VIVO)
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved, lost nearly 40% of its value at one point in 2018.